Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$173K Buy
46,923
+11,691
+33% +$47.3K ﹤0.01% 4792
2026
Q2
$149K Buy
+35,232
New +$162K ﹤0.01% 5081
2026
Q1
– Sell
-19,986
Closed -$114K – 9061
2025
Q4
$142K Buy
+19,986
New +$147K ﹤0.01% 4606
2025
Q3
– Sell
-1,241
Closed -$9.37K – 9052
2025
Q2
$8K Buy
1,241
+670
+117% +$5.34K ﹤0.01% 7441
2025
Q1
$4K Buy
+571
New +$6.73K ﹤0.01% 7635
2024
Q4
– Sell
-771
Closed -$16.5K – 8504
2024
Q3
$17K Buy
771
+251
+48% +$5.79K ﹤0.01% 6782
2024
Q2
$10K Sell
520
-9,310
-95% -$210K ﹤0.01% 7399
2024
Q1
$244K Buy
+9,830
New +$209K ﹤0.01% 4629
2023
Q4
– Sell
-31,534
Closed -$522K – 8763
2023
Q3
$633K Sell
31,534
-34,909
-53% -$798K ﹤0.01% 3151
2023
Q2
$1.7M Buy
66,443
+40,555
+157% +$942K ﹤0.01% 2108
2023
Q1
$550K Buy
25,888
+11,554
+81% +$290K ﹤0.01% 3165
2022
Q4
$424K Buy
14,334
+14,092
+5,823% +$378K ﹤0.01% 3342
2022
Q3
$5K Buy
+242
New +$5.76K ﹤0.01% 8744
2022
Q1
– Sell
-1,557
Closed -$72.7K – 10377
2021
Q4
$94K Buy
+1,557
New +$85.9K ﹤0.01% 6351

Other funds holding BCYC

Simplex Trading's BCYC Position: Q3 2026 in Review

Simplex Trading increased its Bicycle Therapeutics (BCYC) stake by 33% in Q3 2026, buying an estimated $47.3K and bringing the position to 46,923 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #4792.

Simplex Trading first reported a position in BCYC in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.7M in Q2 2023. 25 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Simplex Trading held 46,923 shares of Bicycle Therapeutics worth $173K as of Q3 2026.
  • Simplex Trading bought 11,691 Bicycle Therapeutics shares in Q3 2026, an estimated $47.3K.
  • Bicycle Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4792 holding.
  • Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
  • 25 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.